A Phase III clinical study evaluates the safety, efficacy and related parameters of experimental therapy against a standard therapy in a large human population to as...

”Autoinflammatory” is a term used to describe a group of diseases that cannot be classified as immunological disorders. Autoinflammatory syndromes are a set of genet...

As a clinical trial monitoring technique, risk-based monitoring (or RBM) has become the R&D industry’s de facto monitoring approach to achieve quality data, pati...

The patient-centricity movement has been inspired by the empowerment of patients and patient advocacy groups through the internet, social media and new technology. T...

Targeted therapies for use in clinical studies, such as those in immunooncology (I-O), are the future of pharmaceuticals. Critically assessing the efficacy and safet...

The shift to curative treatments promises to transform the entire healthcare ecosystem. Patients whose conditions were previously managed through ongoing, long-term ...